On January 18, 2026, HSBC analyst Ishan Jain raised Albemarle’s rating to Buy and set a price target of $200, implying a potential upside of 22.67% from its trading level at the time. This upgrade reflects growing confidence in Albemarle’s lithium business, driven by robust demand for electric vehicle batteries and expanding applications in data center energy storage. HSBC cited the company’s cost-reduction initiatives and asset divestitures as key factors supporting long‐term margin expansion.

Over the past month, Albemarle’s shares climbed 31.8%, significantly outpacing the Basic Materials sector’s 8.62% gain. This relative strength contrasts with broader market indices, which showed more modest moves. The surge underscores investor preference for pure‐play lithium exposure at a time when supply constraints and technological advances in battery chemistry are tightening the market for high‐purity lithium hydroxide and carbonate.

Investors are closely watching Albemarle’s Q4 earnings report scheduled for February 11, 2026. Consensus estimates forecast an EPS loss of $0.62, representing a 43.12% improvement year‐over‐year, on revenue of $1.37 billion, up 11.18%. Management’s guidance is expected to emphasize streamlined operations, with planned divestitures of noncore assets and continued investment in lithium refining capacity. Wall Street projections show EBITDA recovering sharply through 2025–2027 as rising lithium prices and production efficiencies drive margin expansion.